Clinical Trial

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Study Description

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

The purpose of this study is to test how soluble epoxide hydrolase (sEH) inhibition with GSK2256294 affects tissue sEH activity and insulin sensitivity.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - GSK2256294

Drug will be taken daily by mouth for 7 days.

Drug - Placebo oral capsule

Placebo will be taken daily by mouth for 7 days.

Additional Information

Official Study Title

Effect of Inhibition Soluble Epoxide Hydrolase on Insulin Sensitivity in Humans

Clinical Trial ID

NCT03486223

ParticipAid ID

BeXgVd